carbostyril has been researched along with Mycoplasma dispar Infection in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Delamaire, F; Gacouin, A; Guillot, P; Lesouhaitier, M; Maamar, A; Painvin, B; Piau, C; Reizine, F; Tadié, JM | 1 |
| Fushimi, K; Imamura, Y; Izumikawa, K; Kawano, K; Kurihara, S; Miyazaki, T; Mukae, H; Saijo, T; Takazono, T; Tashiro, M; Yamamoto, K; Yanagihara, K | 1 |
| Ubukata, K | 1 |
| Bai, L; Cao, B; Gonzalez, R; Guo, P; Liu, YM; Ren, LL; Song, SF; Wang, C; Wang, JW; Yin, YD; Zhang, JZ; Zhang, YY; Zhao, F | 1 |
| Irifune, K; Ishida, K; Kaku, M; Mizukane, R; Suyama, N; Takemura, H; Tanaka, H; Tomono, K; Usui, T; Yoshida, R | 2 |
| Akashi, A; Arai, S; Furudera, T; Gohara, Y; Kuwano, K; Matsubara, S; Matumoto, M; Tseng, CC | 1 |
| Akashi, A; Arai, S; Gohara, Y; Kuwano, K; Nishimoto, M; Oizumi, K; Takeda, K; Yamaguchi, T; Yano, T | 1 |
| Hara, K; Ishida, K; Kaku, M; Koga, H; Kohno, S; Usui, T | 1 |
| Hayashi, Y; Ito, G; Takeyama, S | 1 |
| Azarian, R; Gagnadoux, F; Harzic, M; Lesobre, V; Pangon, B; Petitpretz, P | 1 |
| Hori, R; Kizawa, K; Minami, S; Narita, H; Shimakura, M; Takahata, M; Todo, Y; Watanabe, Y | 1 |
2 review(s) available for carbostyril and Mycoplasma dispar Infection
| Article | Year |
|---|---|
[Mycoplasma pneumoniae].
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Macrolides; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Quinolones; RNA, Ribosomal, 23S | 2013 |
[Mycoplasma pneumoniae pneumopathy. 10 cases].
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Female; Hospitalization; Humans; Macrolides; Male; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Quinolones; Radiography, Thoracic; Retrospective Studies; Risk Factors | 1999 |
1 trial(s) available for carbostyril and Mycoplasma dispar Infection
| Article | Year |
|---|---|
Experimental and clinical studies of sparfloxacin in Mycoplasma pneumoniae infection.
Topics: Animals; Anti-Infective Agents; Cricetinae; Fluoroquinolones; Humans; Lung; Male; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones | 1995 |
9 other study(ies) available for carbostyril and Mycoplasma dispar Infection
| Article | Year |
|---|---|
Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Community-Acquired Infections; Humans; Influenza, Human; Lactams; Legionnaires' Disease; Pneumonia, Mycoplasma; Quinolones; Retrospective Studies | 2023 |
Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study.
Topics: Adult; Aged; Anti-Infective Agents; Databases, Factual; Drug Resistance, Bacterial; Epidemics; Female; Hospitalization; Humans; Japan; Length of Stay; Macrolides; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Quinolones; RNA, Ribosomal, 23S; Tetracycline | 2017 |
Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China.
Topics: Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Female; Humans; Legionella pneumophila; Macrolides; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Viral; Quinolones; Sputum; Streptococcus pneumoniae; Treatment Outcome | 2010 |
In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae.
Topics: Animals; Anti-Infective Agents; Cell Death; Cricetinae; Disease Models, Animal; Erythromycin; Fluoroquinolones; Gatifloxacin; Lung; Male; Mesocricetus; Minocycline; Mycoplasma pneumoniae; Piperazines; Pneumonia, Mycoplasma; Quinolones | 1994 |
In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae.
Topics: Animals; Anti-Infective Agents; Cricetinae; Fluoroquinolones; Humans; Levofloxacin; Lung; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones | 1994 |
In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Cricetinae; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Humans; Lung; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones | 1993 |
Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters.
Topics: Animals; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin; Cricetinae; Female; Fluoroquinolones; Half-Life; Humans; Lung; Mesocricetus; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones | 1993 |
[Clinical study on sparfloxacin (SPFX) in the treatment of mycoplasmal pneumonia and penetration of SPFX to the pneumonic lesion].
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Bacterial Translocation; Bronchoalveolar Lavage Fluid; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mycoplasma; Pneumonia, Mycoplasma; Quinolones | 1998 |
In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae.
Topics: Animals; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Cricetinae; Fluoroquinolones; Indoles; Isoindoles; Lung; Male; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Quinolones | 2001 |